Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
Clinical trial NCT00161941 · COMPLETED
Trial details
- NCT number
- NCT00161941
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2003-06-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.